Welcome to One Virology. We’re a ground-breaking, interdisciplinary team of researchers, bringing together expertise in human and veterinary viruses to make new discoveries, deepen scientific understanding and pioneer novel approaches to challenging infections.
We are made up of around 16 principal investigators and around 40 postdoctoral researchers, technicians and postgraduate students from across the schools of Veterinary Medicine and Science, Life Sciences and Biosciences.
Together, we’ve secured research funding from sources including the EU, MRC, BBSRC, NIHR, DEFRA and NIH (USA), as well as industry and charities. We’re working on projects attracting over £16 million in funding (of which £5 million directly supports research at Nottingham) and in the last five years we’ve published over 200 peer reviewed journals, many collaboratively.
A powerful new perspective
Historically, our researchers focused separately on virus infections within human health and veterinary medicine, mainly aligned to their school specialisms. In 2014, we decided to break the structural barriers between us and come together to achieve even more. Today we call ourselves One Virology.
We’re harnessing our combined expertise to create fresh perspectives, drive exciting projects and make important breakthroughs. This involves building critical mass and seeing real value in working as one, united team. Our research is underpinned by shared doctoral student programmes, regular meetings and scientific seminars, establishing a strong, collaborative future.
Most excitingly, as a result of a successful bid to the Wolfson laboratory refurbishment scheme led by Professor Jonathan Ball, we are planning to co-locate One Virology researchers in a new Centre for Global Virus Research at the Sutton Bonington Campus.
Explore our research themes
To find out more about how our research makes an impact, explore the group’s research themes and projects.
Explore the range of viruses we study within One Virology and find out about our collaborations and publications.
From Ebola to Zika, we’re developing strategies for dealing with some of the most potentially devastating viruses on the planet.
We’re deepening our understanding of disease resistance to unlock new prevention and treatment possibilities.
As a powerful, collaborative team, we are deepening the understanding of viral diseases, paving the way for improved diagnosis, treatment and virus control, and enhancing the health and wellbeing of both people and animals